Conductive Hearing Loss
Understanding Conductive Hearing Loss (CHL): Explore symptoms, causes, diagnosis, and treatment options for CHL, also known as Conductive Deafness. Find information on audiometry testing, medical coding for Conductive Hearing Loss, and clinical documentation best practices. Learn about hearing aids and other assistive devices used in managing CHL. This resource provides valuable insights for healthcare professionals, patients, and coders seeking information related to the C diagnosis of Conductive Hearing Loss.
Hearing loss due to sound conduction problems in the outer or middle ear.
Reduced hearing, muffled sounds, speaks softly, air-bone gap on testing.
Primary care, ENT clinics, audiology departments, hospitals.
ICD-10 Code Families
Complete code families applicable to H90.2
When to use each related code
| Description | When to use |
|---|---|
| Hearing loss due to outer/middle ear problems. | Use for hearing loss from cerumen, otitis media, ossicular issues. Exclude sensorineural causes. |
| Hearing loss due to inner ear or nerve damage. | Use for hearing loss from presbycusis, noise exposure, Meniere's disease. Exclude conductive causes. |
| Hearing loss with both conductive and sensorineural components. | Use when both conductive and sensorineural factors contribute to hearing loss. Document both components. |
Best-practice checklist
- ✓Document air and bone conduction thresholds.
- ✓Specify CHL laterality (unilateral, bilateral).
- ✓Describe onset (sudden, gradual), duration.
- ✓Note any identifiable cause (e.g., cerumen, otitis media).
- ✓Record impact on speech understanding.
Common pitfalls to avoid
Missing or incorrect laterality (right, left, bilateral) for conductive hearing loss can lead to inaccurate coding and claims.
Lack of documentation specifying the underlying cause of CHL (e.g., cerumen, otitis media) can affect code selection and reimbursement.
Misdiagnosis or unclear differentiation between conductive and sensorineural hearing loss may result in inappropriate coding and treatment.
Best-practice tips
- 01Amplification devices (hearing aids, BAHA)
- 02Treat underlying causes (e.g., infections, cerumen)
- 03Surgical intervention (e.g., tympanoplasty, ossiculoplasty)
- 04Regular audiological evaluations ICD-10 H90
- 05Patient education and counseling CPT 92557
Step-by-step checklist
- 1
Verify air conduction poorer than bone conduction (Weber/Rinne tests)
- 2
Confirm airbone gap >10 dB, indicating conductive loss
- 3
Check external/middle ear: obstruction, infection, otosclerosis
- 4
Review medications: ototoxic drugs impacting hearing
- 5
Document laterality (left, right, bilateral) and severity
Ready-to-paste narrative
Patient presents with complaints consistent with conductive hearing loss (CHL), also known as conductive deafness. Symptoms include diminished hearing sensitivity, difficulty understanding speech in noisy environments, and a sensation of fullness or pressure in the affected ear(s). Onset of symptoms was reported as [gradual/sudden] and began approximately [duration] ago. Possible etiologies explored include cerumen impaction, otitis media, otosclerosis, cholesteatoma, and foreign body obstruction. Physical examination revealed [describe findings, e.g., impacted cerumen in the right ear canal, retracted tympanic membrane, etc.]. Audiometric testing demonstrates air-bone gap confirming the conductive nature of the hearing loss. Pure-tone audiometry results indicate [describe specific thresholds and frequencies affected]. Tympanometry findings suggest [describe type, e.g., Type B tympanogram indicative of middle ear effusion]. Diagnosis of conductive hearing loss is made based on patient history, physical examination findings, and audiological test results. Treatment plan includes [describe treatment, e.g., cerumen removal, antibiotic therapy for otitis media, referral to otolaryngology for further evaluation and management of possible otosclerosis or cholesteatoma]. Patient education provided regarding the nature of conductive hearing loss, potential causes, treatment options, and expected outcomes. Follow-up appointment scheduled for [date] to reassess hearing and monitor treatment response. ICD-10 code H90. Medical billing codes will be determined based on specific procedures performed.
Common questions and answers
What are the most effective differential diagnosis strategies for conductive hearing loss (CHL) in adults presenting with impacted cerumen versus middle ear effusion?+
Differentiating between impacted cerumen and middle ear effusion, both common causes of conductive hearing loss in adults, requires a multi-faceted approach. Otoscopic examination is crucial: impacted cerumen appears as a dark brown or yellowish mass obstructing the ear canal, while middle ear effusion presents with a retracted or bulging tympanic membrane, often with an air-fluid level or altered color. Tympanometry helps distinguish the two: a flat tympanogram suggests middle ear fluid, while a normal tympanogram with reduced ear canal volume suggests cerumen impaction. Pure-tone audiometry typically reveals conductive hearing loss in both conditions, but bone conduction thresholds remain normal. Exploring pneumatic otoscopy can further enhance diagnostic accuracy by assessing tympanic membrane mobility. Consider implementing a standardized protocol incorporating these techniques to ensure accurate diagnosis and appropriate management for each condition. Explore how combining otoscopy, tympanometry, and audiometry improves diagnostic certainty in CHL cases.
How can I distinguish between otosclerosis and other causes of conductive hearing loss when evaluating a young adult patient with gradual onset hearing loss and a normal tympanic membrane?+
While a normal-appearing tympanic membrane can complicate the diagnosis of conductive hearing loss in young adults, it’s important to consider otosclerosis in the differential, especially with gradual onset. Although otosclerosis often presents with a reddish hue behind the tympanic membrane (Schwartze's sign), this isn't always visible. Crucially, differentiating it from other causes like ossicular chain discontinuity or congenital cholesteatoma requires careful audiological assessment. Carhart's notch, a characteristic bone-conduction dip at 2kHz, though not always present, can suggest otosclerosis. High-resolution CT imaging of the temporal bone is essential for visualizing the characteristic foci of otosclerosis affecting the stapes footplate. Learn more about the diagnostic value of comparing air and bone conduction thresholds at various frequencies, particularly at 2 kHz, in suspected otosclerosis cases. Explore the role of advanced imaging techniques in confirming otosclerosis and ruling out other subtle middle ear pathologies.
What are the best practice guidelines for managing conductive hearing loss related to chronic otitis media with effusion in pediatric patients, considering the potential long-term developmental implications?+
Managing conductive hearing loss secondary to chronic otitis media with effusion (OME) in children requires a balanced approach, recognizing potential developmental impacts. Initial management often includes watchful waiting with regular monitoring of hearing and middle ear status. If OME persists beyond 3 months and hearing loss is significant, particularly affecting speech and language development, intervention becomes necessary. Options include short-term courses of oral corticosteroids, antibiotics if a concurrent bacterial infection is suspected, or surgical intervention like myringotomy with or without tympanostomy tube placement. Long-term follow-up is essential to monitor hearing recovery, language development, and potential complications. Consider implementing a multidisciplinary approach involving audiologists, speech-language pathologists, and otolaryngologists to optimize outcomes. Learn more about the latest evidence-based recommendations for OME management in children, focusing on minimizing the risk of long-term developmental delays.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.